Lingohr Asset Management’s Biogen BIIB Stock Holding History

Lingohr Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,505	Closed	-$742K	–	74
2019 Q4	$742K	Hold	2,505	–	–	0.72%	83
2019 Q3	$583K	Hold	2,505	–	–	0.58%	81
2019 Q2	$586K	Buy	2,505 +700	+39%	+$162K	0.58%	85
2019 Q1	$427K	Buy	+1,805	New	+$568K	0.44%	95
2018 Q2	–	Sell	-3,803	Closed	-$1.04M	–	111
2018 Q1	$1.04M	Buy	3,803 +648	+21%	+$201K	0.65%	76
2017 Q4	$1M	Sell	3,155 -59	-2%	-$18.9K	0.53%	74
2017 Q3	$1.01M	Hold	3,214	–	–	0.52%	73
2017 Q2	$879K	Sell	3,214 -310	-9%	-$82K	0.51%	69
2017 Q1	$964K	Buy	+3,524	New	+$996K	0.53%	71

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lingohr Asset Management's BIIB Position: Q1 2020 in Review

Lingohr Asset Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 2,505 shares — an estimated $742K sold.

Lingohr Asset Management first reported a position in BIIB in Q1 2017 and held it in 9 quarters. The position peaked at $1.04M in Q1 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

Lingohr Asset Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
Lingohr Asset Management sold 2,505 Biogen shares in Q1 2020, an estimated $742K.
Lingohr Asset Management first reported a position in Biogen in Q1 2017 and held it in 9 quarters.
Lingohr Asset Management's Biogen position peaked at $1.04M in Q1 2018.
1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Lingohr Asset Management's 13F filing for Q1 2020, filed 7 May 2020.